NEA Management Company, LLC

NEA Management Company, LLC serves as the management entity for New Enterprise Associates (NEA), one of the world's largest and most established venture capital firms. Headquartered in Chevy Chase, Maryland, NEA has operated since 1977, making it one of the longest-tenured venture capital franchises in the United States. The firm files quarterly 13F reports with the SEC under CIK #0001512848, disclosing public equity holdings that typically represent post-IPO positions in companies NEA backed during earlier private funding stages. NEA's institutional stature has been built across more than four decades of venture investing, with the firm having raised numerous multi-billion dollar funds and backing companies that have achieved landmark public offerings and strategic acquisitions. The partnership model brings together technology-focused investors with healthcare and life sciences specialists, creating a diversified venture platform under unified management. NEA maintains additional offices in Menlo Park, California, and internationally, positioning the firm to source opportunities across major innovation ecosystems. Through the platform's 13F History tools, analysts can track NEA's public equity holdings—predominantly representing continued stakes in portfolio companies following their transitions to public markets.

NEA Management Company executes a multi-stage venture capital strategy spanning seed investments through growth equity, with particular depth in technology and healthcare sectors. The firm's investment approach combines early-stage company building with later-stage growth capital deployment, allowing NEA to participate across the full private company lifecycle. 13F Portfolio Composition reflects this venture heritage, as disclosed holdings predominantly consist of public equities in companies NEA backed during private funding rounds—representing harvesting positions rather than open-market stock selection. The technology mandate encompasses enterprise software, cybersecurity, fintech, consumer internet, and infrastructure platforms, while healthcare investments span biopharmaceuticals, medical devices, diagnostics, and healthcare IT. NEA's investment team brings deep sector expertise, with partners often possessing operational backgrounds or extensive domain specialization in their focus areas. The firm's willingness to lead rounds and take board seats distinguishes its approach from passive venture investors, with active portfolio company engagement continuing through public market transitions. Top 10 Holdings Concentration analysis through the platform reveals how post-IPO positions in successful venture investments dominate NEA's disclosed equity portfolio, with individual company outcomes significantly impacting aggregate results. The long holding period characteristic of venture investing—often spanning seven to ten years from initial investment to public offering—creates 13F disclosure patterns distinct from traditional hedge fund or asset manager filings.

NEA Management Company represents one of venture capital's most enduring franchises, with the firm's Chevy Chase headquarters serving as the operational center for a global investment platform spanning technology and healthcare sectors. The 13F filings provide a window into NEA's public equity holdings, though these positions represent post-IPO stakes in venture-backed companies rather than traditional public market portfolio construction. Under leadership including Managing General Partner Scott Sandell, NEA has maintained its position among the largest venture capital firms globally, raising successive multi-billion dollar funds and backing numerous companies through initial public offerings. Annualized Return (CAGR) examination through backtesting tools can quantify the compounding behavior of NEA's disclosed public equity portfolio, though users should recognize this captures harvesting-stage positions rather than the full venture capital return profile that includes private company value creation. Sector Allocation History analysis illuminates the technology-healthcare balance within public holdings and how this mix has evolved as different vintage investments achieved liquidity. Observable characteristics include concentrated positioning in growth-oriented companies, extended holding periods extending beyond IPO events, and sector concentration reflecting NEA's venture investment specialization. For allocators and analysts examining NEA's approach through 13F disclosures, a critical diagnostic question emerges: How do post-IPO holding decisions—determining when to distribute shares versus maintain positions—impact realized returns during different market environments for venture-backed technology and healthcare equities?

The risk characteristics observable through NEA's 13F filings reflect the unique dynamics of venture capital public equity holdings rather than traditional portfolio construction. Disclosed positions represent continued ownership in companies NEA backed during private stages, meaning concentration levels and sector exposures derive from venture investment selection rather than public market portfolio optimization. Max Drawdown Depth analysis through historical replication captures how these post-IPO holdings perform through market cycles, with technology and healthcare growth stocks often exhibiting elevated volatility relative to broad market indices. The venture capital holding pattern—where positions reflect ownership built through private funding rounds—means traditional diversification metrics may not capture the portfolio's actual risk architecture, which includes substantial private company exposures not visible in 13F filings. NEA's technology and healthcare focus introduces sector-specific risk factors including regulatory outcomes for healthcare companies, competitive dynamics in technology markets, and growth-to-value rotation impacts across both sectors. Volatility Profile examination reveals how concentrated growth equity positions can produce substantial return dispersion during market regime shifts, particularly during risk-off periods when unprofitable or early-stage public companies experience valuation compression. The firm's long-term investment horizon and institutional limited partner base provide flexibility to maintain positions through volatility, though 13F-observable holdings represent only public equity exposures within NEA's broader private-company-dominated portfolio.